Economic impact of steroid-induced comorbidities in severe asthma: a SHARP CRC simulationERJ OPEN RESEARCHIF42025-11-171PRE
Newly diagnosed eosinophilic granulomatosis with polyangiitis in patients on biologics for severe asthma: A multicenter case series新诊断的嗜酸性肉芽肿性多血管炎在生物制剂治疗重症哮喘患者中的多中心病例系列The Journal of Allergy and Clinical Immunology: In PracticeIF02025-04-150PRE
Severe Fatigue in Uncontrolled Asthma: Contributing Factors and Impact of RehabilitationJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICEIF6.62024-12-010OAAI
Characteristics of severe asthma patients requiring ICU treatment across the SHARP CRCEUROPEAN RESPIRATORY JOURNALIF212024-10-300PRE
Initial data analysis of the SHARP CRC patient population reveals a large heterogeneity among European patients with severe asthmaEUROPEAN RESPIRATORY JOURNALIF212024-10-300PRE
Clinical characteristics of severe asthma patients in Europe, according to the percentage of GDP spent on healthcare- a SHARP-CRC studyEUROPEAN RESPIRATORY JOURNALIF212024-10-300PRE
Health-related quality of life (HRQoL) in depression defined by clinicians and patients in severe asthma. Data from SHARP CRCEUROPEAN RESPIRATORY JOURNALIF212024-10-300PRE
Multimorbidity burden in severe asthma across the SHARP CRCEUROPEAN RESPIRATORY JOURNALIF212024-10-300PRE
Severe fatigue in uncontrolled asthma: impact of alpine altitude climate rehabilitation and predictive factors for persistent severe fatigueEUROPEAN RESPIRATORY JOURNALIF212024-10-300PRE
Real-world changes in fatigue in severe asthma patients after starting anti-interleukin-4/13 biologicEUROPEAN RESPIRATORY JOURNALIF212024-10-300PRE
The SHARP CRC Health Economics Study. Simulation of the preventable costs of oral corticosteroids in severe asthmatics in eleven European countriesEUROPEAN RESPIRATORY JOURNALIF212024-10-300PRE
Health-related quality of life and asthma control in patients receiving or not receiving biologic treatments for severe asthma. Data from SHARP CRCEUROPEAN RESPIRATORY JOURNALIF212024-10-300PRE
The patient health-related quality of life (HRQoL) burden of severe asthma in Europe (SHARP CRC) for specific subgroupsEUROPEAN RESPIRATORY JOURNALIF212024-10-300PRE
Characteristics of never-, switching, and persisting users of biologics for severe asthma - SHARP-CRC studyEUROPEAN RESPIRATORY JOURNALIF212024-10-300PRE
Relationship between the Severe Asthma Questionnaire and the EQ-5D-5L for health- related quality of life in the SHARP CRC registryEUROPEAN RESPIRATORY JOURNALIF212024-10-300PRE
Severe Asthma Multimorbidity Clusters Across Europe; Findings From SHARPEUROPEAN RESPIRATORY JOURNALIF212024-10-300PRE
Heterogeneity of comorbidities captured by European national severe asthma registries in SHARP CRCEUROPEAN RESPIRATORY JOURNALIF212024-10-300PRE
Reply to Impact of oral corticosteroid on long-term weight following initiation of anti-IL-5/5Ra biologics in severe asthmaJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICEIF6.62024-02-010OAAI
Effect of dietary interventions on markers of type 2 inflammation in asthma: A systematic review饮食干预对哮喘患者2型炎症标志物影响的系统评价RESPIRATORY MEDICINEIF3.12024-01-014OAAI
Dietary Inflammatory Index and Clinical Outcome Measures in Adults With Moderate-to-Severe AsthmaJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICEIF6.62023-12-015OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向